Downstream Processing Market Size, Share, and Trends

Downstream Processing Market (By Product: Centrifuges, Dryers, Chromatography Systems, Filters, Evaporators, Others; By Application: Antibodies Production, Antibiotic Production, Hormone Production, Enzyme Production, Vaccine Production; By Technique: Purification by Chromatography, Solid-liquid Separation, Cell Disruption, Concentration, Formulation) - Global Market Size, Trends Analysis, Segment Forecasts, Regional Outlook 2024 - 2033

  • Last Updated : June 2024
  • Report Code : 1072
  • Category : Healthcare

Downstream Processing Market Size and Growth 2024 to 2033

The global downstream processing market was valued at USD 27.36 billion in 2023 and is expected to hit over USD 101.43 billion by 2033, growing at a CAGR of 14% over the forecast period from 2024 to 2033.

Downstream Processing Market Size 2024 to 2033

Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare

Downstream Processing Market Key Takeaways

  • North America dominated the global market with a major market share of 36.14% in 2023.
  • Asia-Pacific is expected to expand at the fastest CAGR between 2024 and 2033.
  • By Application, the antibiotic production segment generated revenue share of 34% in 2023.
  • By Technique, the monoclonal antibody medication segment contributed more than 42% of revenue share in 2023.
  • By Product, the thalassemia segment has held the biggest revenue share of 43% in 2023.

U.S. Downstream Processing Market Size and Growth 2024 to 2033

The U.S. downstream processing market size was estimated at USD 6.93 billion in 2023 and is predicted to be worth around USD 27.20 billion by 2033, at a CAGR of 14.64% from 2024 to 2033.

U.S. Downstream Processing Market Size 2024 to 2033

In 2023, North America acquired a maximum market share of 36.14% in the downstream processing sector and is projected to maintain this strong hold throughout the valuation period. This growth market is impelled by the accumulative demand for biopharmaceuticals and snowballing Research and development spending in the biopharmaceutical sector. Emergent markets like Asia Pacific deliver innovative growth openings to performers in the market. However, requirement for trained professionals and more cost of instruments are estimated to confine market growth during next few years. Further,absence of single-use choices, purification bottleneck, and harm to the health of capable professionals are few foremost problems in the downstream processing marketplace.

Asia Pacific region is anticipated to record a substantial growth rate of 18% throughout the prediction period. Nations such as India, China, Japan, and South Korea, are projected to motivate the requirement for downstream processing produces in the impending years. In addition, growth in these markets will be powered by cumulative government support, noteworthy investments by significant marketplace performers, emerging R&D infrastructure, and budding academic fineness and expertise among others.

Downstream Processing Market Share, By Region, 2023 (%)

Downstream Processing Market Growth Factors

Since past few years higher productivity upstream processes are flourishing greater speeds and capacities in downstream techniques for the protein purification. This is evidently observed in the extensively employed affinity supports comprising Protein A as the precise binding ligand. Downstream processing means retrieval and refinement of biosynthetic products from natural sources including animal tissue or plant tissue. For instance, downstream processing is a significant phase in the antibiotics manufacture like penicillin. The process encompasses separation and purification of antibiotics from an array of mediums. Downstream technology is increasingly being employed in both industrial-scale and laboratory applications due to a upward need for biologics, which is anticipated to lift the downstream processing market growth during years to come.

Further, cumulative demand for biosynthetic products for secondary use in pharmaceutics is the vital influence propelling the downstream processing sector. Currently, naturally sourced pharmaceuticals progressively perceive demand on account of their less risk of side-effects. A stablesurge in the sale for drug quality or recombinant products is pushing the embracing downstream processing considerably. Furthermore,escalation in the perception of the large molecules and biologics is foreseen to elevate the acceptance of downstream methodologies.

Downstream Processing Market Scope

Report Highlights Details
Downstream Processing Market Size in 2023 USD 27.36 Billion
Downstream Processing Market Size by 2033 USD 101.43 Billion
Downstream Processing Market Growth Rate from 2024 to 2033 CAGR of 14%
Fastest Growing Market Asia Pacific
Largest Market North America
Base Year 2023
Forecast Period 2024 to 2033
Segments Covered By Vehicle Class, and By Architecture
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

 

Application Insights

Among different application segment, the antibiotic production appeared as most dominating application in 2023 with a revenue share of 34%. They are employed in the treatment of numeral illnesses such as cancers and number of infectious ailments. Particulβ-lactam antibiotics such as penicillin and cephalosporin are some of the most frequently commercialized antibiotics classes across the globe. Natural penicillin and cephalosporin are produced at an industrial scale via bioprocessing methods and are harvested with the help of downstream processing.

Technique Insights

The purification using chromatography segment has held a 42% revenue share in 2023. This technique is employed is in the purification and separation of the highest value products. This is a crucial stage technique that can be engaged at any stage of downstream processing till the concluding step of purification. Additionally, solid-liquid separation division is projected to record the fastest growth rate during years to come.

Product Insights

In 2023, the chromatography segment conquered the global downstream processing market revenue with a maximum share of around 43%. Numerous companies offer safe and integrated solutions that work proficiently throughout the vigorous stages from process development till production scale. Technological progressions have resulted in the development of single-use chromatography, which is deliberated a vibrant invention in the sector of bio pharmacy and is projected to observe encouraging progress throughout the prognosis timeframe. Nonetheless, filters sector is estimated to show the firmest growth rate in downstream processing market in the upcoming period.

Downstream Processing Market Companies

  • BoehringerIngelheim
  • Danaher Corporation
  • Sartorius Stedium Biotech S.A
  • GE Healthcare
  • Merck Millipore
  • Eppendorf AG
  • 3M Company
  • Thermo Fisher Scientific Inc
  • Finesse Solutions Inc
  • Lonza Group

Segments Covered in the Report

By Product

  • Centrifuges
  • Dryers
  • Chromatography Systems
  • Filters
  • Evaporators
  • Others

By Application

  • Antibodies Production
  • Antibiotic Production
  • Hormone Production
  • Enzyme Production
  • Vaccine Production

By Technique

  • Purification by Chromatography
  • Solid-liquid Separation
    • Centrifugation
    • Filtration
  • Cell Disruption
  • Concentration
  • Formulation

By Regional Outlook

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Middle East & Africa
  • Latin America

Frequently Asked Questions

The global downstream processing market size was reached at USD 27.36 billion in 2023 and is anticipated to rake USD 101.43 billion by 2033.

The global downstream processing market is expected to grow at a CAGR of 14% over forecast period 2024 to 2033.

In 2023, North America acquired maximum market share in downstream processing sector and is projected to maintain this strong hold throughout the valuation period.

Asia Pacific region is anticipated to record substantial growth rate throughout the prediction period.

Escalation in R&D expenditure by biopharmaceutical establishments and uptake in demand for biopharmaceuticals greatly fuels the growth of downstream processing market across the globe.

The key players operating in the downstream processing marketplace are General Electric Company, Thermo Fisher Scientific, Inc., Danaher Corporation, Merck & Co Inc., Corning Incorporated, 3M Company, Repligen Corporation, Eppendorf AG, and Lonza Group Ltd.

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global Downstream Processing Market, By Product

7.1. Downstream Processing Market, by Product Type, 2024-2033
7.1.1. Centrifuges
7.1.1.1. Market Revenue and Forecast (2021-2033)
7.1.2. Dryers
7.1.2.1. Market Revenue and Forecast (2021-2033)
7.1.3. Chromatography Systems
7.1.3.1. Market Revenue and Forecast (2021-2033)
7.1.4. Filters
7.1.4.1. Market Revenue and Forecast (2021-2033)
7.1.5. Evaporators
7.1.5.1. Market Revenue and Forecast (2021-2033)
7.1.6. Others
7.1.6.1. Market Revenue and Forecast (2021-2033)

Chapter 8. Global Downstream Processing Market, By Application

8.1. Downstream Processing Market, by Application, 2024-2033
8.1.1. Antibodies Production
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Antibiotic Production
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Hormone Production
8.1.3.1. Market Revenue and Forecast (2021-2033)
8.1.4. Enzyme Production
8.1.4.1. Market Revenue and Forecast (2021-2033)
8.1.5. Vaccine Production
8.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Downstream Processing Market, By Technology

9.1. Downstream Processing Market, by Technology, 2024-2033
9.1.1. Purification by Chromatography
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Solid-liquid Separation
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. Cell Disruption
9.1.3.1. Market Revenue and Forecast (2021-2033)
9.1.4. Concentration
9.1.4.1. Market Revenue and Forecast (2021-2033)
9.1.5. Formulation
9.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Downstream Processing Market, Regional Estimates and Trend Forecast

10.1. North America
10.1.1. Market Revenue and Forecast, by Product (2021-2033)
10.1.2. Market Revenue and Forecast, by Application (2021-2033)
10.1.3. Market Revenue and Forecast, by Technology (2021-2033)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Product (2021-2033)
10.1.4.2. Market Revenue and Forecast, by Application (2021-2033)
10.1.4.3. Market Revenue and Forecast, by Technology (2021-2033)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Product (2021-2033)
10.1.5.2. Market Revenue and Forecast, by Application (2021-2033)
10.1.5.3. Market Revenue and Forecast, by Technology (2021-2033)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product (2021-2033)
10.2.2. Market Revenue and Forecast, by Application (2021-2033)
10.2.3. Market Revenue and Forecast, by Technology (2021-2033)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Product (2021-2033)
10.2.4.2. Market Revenue and Forecast, by Application (2021-2033)
10.2.4.3. Market Revenue and Forecast, by Technology (2021-2033)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Product (2021-2033)
10.2.5.2. Market Revenue and Forecast, by Application (2021-2033)
10.2.5.3. Market Revenue and Forecast, by Technology (2021-2033)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Product (2021-2033)
10.2.6.2. Market Revenue and Forecast, by Application (2021-2033)
10.2.6.3. Market Revenue and Forecast, by Technology (2021-2033)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Product (2021-2033)
10.2.7.2. Market Revenue and Forecast, by Application (2021-2033)
10.2.7.3. Market Revenue and Forecast, by Technology (2021-2033)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product (2021-2033)
10.3.2. Market Revenue and Forecast, by Application (2021-2033)
10.3.3. Market Revenue and Forecast, by Technology (2021-2033)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Product (2021-2033)
10.3.4.2. Market Revenue and Forecast, by Application (2021-2033)
10.3.4.3. Market Revenue and Forecast, by Technology (2021-2033)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Product (2021-2033)
10.3.5.2. Market Revenue and Forecast, by Application (2021-2033)
10.3.5.3. Market Revenue and Forecast, by Technology (2021-2033)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Product (2021-2033)
10.3.6.2. Market Revenue and Forecast, by Application (2021-2033)
10.3.6.3. Market Revenue and Forecast, by Technology (2021-2033)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Product (2021-2033)
10.3.7.2. Market Revenue and Forecast, by Application (2021-2033)
10.3.7.3. Market Revenue and Forecast, by Technology (2021-2033)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product (2021-2033)
10.4.2. Market Revenue and Forecast, by Application (2021-2033)
10.4.3. Market Revenue and Forecast, by Technology (2021-2033)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Product (2021-2033)
10.4.4.2. Market Revenue and Forecast, by Application (2021-2033)
10.4.4.3. Market Revenue and Forecast, by Technology (2021-2033)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Product (2021-2033)
10.4.5.2. Market Revenue and Forecast, by Application (2021-2033)
10.4.5.3. Market Revenue and Forecast, by Technology (2021-2033)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Product (2021-2033)
10.4.6.2. Market Revenue and Forecast, by Application (2021-2033)
10.4.6.3. Market Revenue and Forecast, by Technology (2021-2033)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Product (2021-2033)
10.4.7.2. Market Revenue and Forecast, by Application (2021-2033)
10.4.7.3. Market Revenue and Forecast, by Technology (2021-2033)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product (2021-2033)
10.5.2. Market Revenue and Forecast, by Application (2021-2033)
10.5.3. Market Revenue and Forecast, by Technology (2021-2033)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Product (2021-2033)
10.5.4.2. Market Revenue and Forecast, by Application (2021-2033)
10.5.4.3. Market Revenue and Forecast, by Technology (2021-2033)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Product (2021-2033)
10.5.5.2. Market Revenue and Forecast, by Application (2021-2033)
10.5.5.3. Market Revenue and Forecast, by Technology (2021-2033)

Chapter 11. Company Profiles

11.1. BoehringerIngelheim
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Danaher Corporation
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Sartorius Stedium Biotech S.A
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. GE Healthcare
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Merck Millipore
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Eppendorf AG
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. 3M Company
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Thermo Fisher Scientific Inc
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Finesse Solutions Inc
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Lonza Group
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions

Chapter 13. Appendix

13.1. About Us
13.2. Glossary of Terms

Proceed To Buy

USD 4900
USD 3800
USD 2100
USD 2100
USD 7500

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client